The SARS-COV2 (COVID-19) Pandemic: What Clinicians should Know
Afro-Egypt. j. infect. enem. dis
; 10(2): 75-92, 2022. figures, tables
Article
in English
| AIM
| ID: biblio-1426322
Responsible library:
CG1.1
ABSTRACT
In late 2019, a novel coronavirus, now designated SARS-CoV-2, emerged and was identified as the cause of an outbreak of acute respiratory illness in Wuhan, a city in China, named as COVID-19. Since then the waves of the virus exponentially hit many countries around the globe with high rates of spread associated with variable degrees of morbidity and mortality. The WHO announced the pandemic state of the infection in March 2020 and by June 1st 2020 more than 6 million individuals and more than 370 thousands case fatalities were documented worldwide. In this article, we discussed many aspects regarding this emerged infection based on the available evidence aiming to help clinician to improve not only their knowledge but also their practices toward this infection.
Full text:
Available
Index:
AIM (Africa)
Main subject:
Indicators of Morbidity and Mortality
/
SARS-CoV-2
/
COVID-19
Type of study:
Prognostic study
Language:
English
Journal:
Afro-Egypt. j. infect. enem. dis
Year:
2022
Type:
Article
Institution/Affiliation country:
Clinical Program, Faculty of Pharmacy, Zagazig University/EG
/
Department of Dermatology, Venereology and Andrology, Faculty of Medicine,/EG
/
Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine/EG
/
Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Kafrelshiekh University/EG
/
Department of Radiology, Faculty of Medicine, Kafrelshiekh University/EG
/
Department of Tropical Medicine, Faculty of Medicine, Zagazig University/EG
/
Department of Tropical Medicine, Faculty of Medicine, Zagazig University,/EG
Similar
MEDLINE
...
LILACS
LIS